Quodria Ltd
Home
Indications
  • Atopic Dermatitis
  • Psoriasis
PROJECTS
  • Q001
  • Q002
  • Q003
  • Base formulation
Our Team
Quodria News
Investment
Contact us
Quodria Ltd
Home
Indications
  • Atopic Dermatitis
  • Psoriasis
PROJECTS
  • Q001
  • Q002
  • Q003
  • Base formulation
Our Team
Quodria News
Investment
Contact us
More
  • Home
  • Indications
    • Atopic Dermatitis
    • Psoriasis
  • PROJECTS
    • Q001
    • Q002
    • Q003
    • Base formulation
  • Our Team
  • Quodria News
  • Investment
  • Contact us

  • Home
  • Indications
    • Atopic Dermatitis
    • Psoriasis
  • PROJECTS
    • Q001
    • Q002
    • Q003
    • Base formulation
  • Our Team
  • Quodria News
  • Investment
  • Contact us

BASE FORMULATION

Our base formulation has been expertly developed in-house and has high quality aesthetic properties with a great look and feel.


The light, moisturising formulation is compatible with a range of active ingredients; small molecule, peptide, protein, nucleic acids and is shelf-stable with no specific storage requirements.


The manufacturing process is easily scalable for manufacturing, and our expert scientists have ensured that it is fully compatible with analytical methods.

DISCOVER OUR TREATMENTS

Q001 - A NEW FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITISQ002 - A NEW BEST-IN-CLASS TREATMENT FOR ATOPIC DERMATITISQ003 - A NEW FIRST-IN-CLASS TREATMENT FOR PSORIASIS

Copyright © 2025 Quodria Ltd - All Rights Reserved.

Powered by

  • Investment
  • Contact us
  • Privacy Policy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept